Ieq Capital LLC Sells 893 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Ieq Capital LLC trimmed its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 80.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 216 shares of the medical instruments supplier’s stock after selling 893 shares during the period. Ieq Capital LLC’s holdings in Mettler-Toledo International were worth $264,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Seilern Investment Management Ltd purchased a new stake in Mettler-Toledo International during the 4th quarter valued at $89,221,000. AustralianSuper Pty Ltd lifted its holdings in shares of Mettler-Toledo International by 3,183.2% in the 4th quarter. AustralianSuper Pty Ltd now owns 71,673 shares of the medical instruments supplier’s stock worth $87,705,000 after acquiring an additional 69,490 shares during the last quarter. Canoe Financial LP boosted its stake in shares of Mettler-Toledo International by 576.5% during the 4th quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock worth $67,936,000 after purchasing an additional 47,311 shares during the period. Principal Financial Group Inc. grew its holdings in Mettler-Toledo International by 13.9% during the 4th quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares during the last quarter. Finally, Retirement Systems of Alabama raised its position in Mettler-Toledo International by 610.4% in the 3rd quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock worth $50,183,000 after purchasing an additional 28,752 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at $964,248.46. The trade was a 51.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,530 shares of company stock valued at $2,024,192. 1.94% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

MTD has been the subject of several recent analyst reports. Stifel Nicolaus dropped their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,368.00.

Mettler-Toledo International Price Performance

NYSE:MTD opened at $1,271.44 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93. The company has a 50-day moving average of $1,291.19 and a 200 day moving average of $1,330.22. The firm has a market cap of $26.59 billion, a PE ratio of 31.37, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.